Skip to main content
. 2021 May 24;34(1):171–179. doi: 10.1111/den.14010

Table 1.

Patients’ characteristics

Group A Group B P value
Number of patients (n) 99 97
Age (years) 64.8 ± 13.9 63.4 ± 13.3 0.45
Sex, male 48 (48.5%) 51 (52.6%) 0.57
BMI (kg/m2) 23.2 ± 4.0 22.5 ± 2.8 0.17
Alcohol drinking 48 (48.5%) 37 (38.1%) 0.15
Smoking 38 (38.4%) 34 (35.1%) 0.66
History of colonoscopy 46 (46.4%) 46 (47.4%) 1.00
Using laxative 5 (5.0%) 5 (5.2%) 1.00
Using sleeping pills 4 (4.0%) 4 (4.1%) 1.00
Using antithrombotic agents 15 (15.2%) 15 (15.5%) 1.00
Comorbidity
Cardiovascular diseases 14 (14.1%) 17 (17.5%) 0.56
Cerebrovascular diseases 5 (5.0%) 9 (9.3%) 0.28
Chronic kidney diseases 3 (3.0%) 1 (1.0%) 0.62
Chronic liver damage 5 (5.0%) 5 (5.2%) 1.00
Diabetes mellitus 14 (14.1%) 7 (7.2%) 0.17
Hypertension 35 (35.4%) 40 (41.2%) 0.46
Malignant diseases 22 (22.2%) 15 (15.5%) 0.27
Charlson comorbidity score 1.4 ± 1.7 1.2 ± 1.2 0.38

BMI, body mass index. Results are presented as mean ± standard deviation or number of patients.